Abstract
The purpose of this study was to evaluate fertility after different types of post-chemotherapy retroperitoneal lymph node dissection (RPLND). During 1980–1994, 192 patients with metastatic testicular cancer underwent post-chemotherapy RPLND with a gradual shift from modified bilateral template RPLND to nerve-sparing RPLND. Modified bilateral template RPLND was done in 92% of the patients operated during 1980–1984 as compared to 16% during 1989–1994. Pre- and post-treatment fertility was assessed by microscopic sperm analysis, determination of serum FSH and information on ejaculation and paternity. There was no significant difference of the survival rates between the three treatment periods. Antegrade ejaculation was preserved in 11% of the patients after modified bilateral template RPLND as compared to 89% after the nerve-sparing operation technique. The median ejaculatory volume decreased post-operatively, serum FSH increased and sperm density remained unchanged. Fifty-six patients attempted fatherhood after their treatment, and 27 fathered at least one child after an observation-time of 55 months, nine of them by assisted fertilization. Patients with initially advanced testicular cancer but limited residual retroperitoneal masses after induction chemotherapy can safely undergo limited post-chemotherapy RPLND as a part of multimodality treatment. After nerve-sparing RPLND antegrade ejaculation is preserved in 89% of the patients though the ejaculatory volume decreases after RPLND. Post-treatment fatherhood can be achieved in at least 50% of the patients attempting paternity.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aass, N. & Fosså, S. D. (1988) Paternity in young patients with testicular cancer expectations and experience. Prog Clin Biol Res 269: 481–491.
Aass, N., Fosså, S. D., Aas, M. & Lindegaard, M. W. (1990) Renal function related to different treatment modalities for malignant germ cell tumours. Br J Cancer 62: 842–846.
Aass, N., Fosså, S. D., Theodorsen, L. & Norman, N. (1991) Prediction of long-term gonadal toxicity after standard treatment for testicular cancer. Eur J Cancer 27: 1087–1091.
Bajorin, D. F., Sarosdy, M. F., Pfister, D. G., Mazumdar, M., Motzer, R. J., Scher, H. I., Geller, N. L., Fair, W. R., Herr, H., Sogani, P., Sheinfeld, J., Russo, P., Vlamis, V., Carey, R., Vogelzang, N. J., Crawford, E. D. & Bosl, G. J. (1993) Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 11: 598–606.
Berthelsen, J. G. (1984) Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer. Fertil Steril 41: 281–286.
Bissett, D., Kunkeler, L., Zwaneburg, L., Paul, J., Gray, C., Swan, I. R. C., Kerr, D. J. & Kaye, S. B. (1990) Long-term sequelae of treatment for testicular germ cell tumours. Br J Cancer 62: 655–659.
Bosl, G. J. & Motzer, R. J. (1997) Testicular germ-cell cancer. Review Art. N Engl J Med 337: 242–253.
Brenner, J., Vugrin, D. & Whitmore, W. F. Jr (1985) Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis. Am J Clin Oncol 8: 178–182.
Donohue, J. P., Foster, R. S., Rowland, R. G., Bihrle, R., Jones, R. & Geier, G. (1990) Nervesparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144: 287–292.
Drasga, R. E., Einhorn, L. H., Williams, S. D., Patel, D. N. & Stevens, E. E. (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 1: 179–183.
Fosså, S. D., Klepp, O., Ous, S., Lien, H. H., Stenwig, A. E., Åbyholm, T. & Kaalhus, O. (1984a) Unilateral retroperitoneal lymph node dissection in patients with nonseminomatous testicular tumor in clinical stage. I. Eur Urol 10: 17–23.
Fosså, S. D., Klepp, O., Ous, S., Lien, H. H., Stenwig, J. T., Abeler, V., Eliassen, G. & HØst, H. (1984b) Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cisplatinum-based chemotherapy. Scand J Urol Nephrol 18: 21–26.
Fosså, S. D., Ous, S., Åbyholm, T. & Loeb, M. (1985a) Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency. Br J Urol 57: 204–209.
Fosså, S. D., Ous, S., Åbyholm, T., Norman, N. & Leob, M. (1985b) Post-treatment fertility in patients with testicular cancer. II. Influence of cisplatin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 57: 210–214.
Fosså, S. D., Borge, L., Aass, N., Johannessen, N. B., Stenwig, A. E. & Kaalhus, O. (1987) The treatment of advanced metastatic seminoma: Experience in 55 cases. J Clin Oncol 5: 1071–1077.
Fosså, S. D., Aass, N. & Kaalhus, O. (1988) Testicular cancer in young Norwegians. Surg Oncol 39: 43–63.
Fosså, S. D., Aass, N., Ous, S. & Waehre, H. (1991) Long-term morbidity and quality of life in testicular cancer patients. Scand J Urol Nephrol Suppl 138: 241–246.
Fosså, S. D., Qvist, H., Stenwig, A. E., Lien, H. H., Ous, S. & Giercksky, K. E. (1992) Is postchemotherapy retroperitoneal surgery necessary in patients with non-seminomatous testicular cancer and minimal residual tumor masses?. J Clin Oncol 10: 569–573.
Hendry, W. F., A’Hern, R. P., Hetherington, J. W., Peckham, M. J., Dearnaley, D. P. & Horwich, A. (1993) Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: Prognostic value and therapeutic benefit. Br J Urol 71: 208–213.
Hermanek, P. & Sigel, A. (1982) Necessary extent of lymph node dissection in testicular tumours. A histopathological investigation. Eur Urol 8: 135–144.
Hollender, Å, Stenwig, E. A., Ous, S. & Fosså, S. D. (1997) Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy. Eur Urol 31: 141–147.
Jewett, M. A. S., Kong, Y. S. P., Goldberg, S. D., Sturgeon, J. F. C., Thomas, G. M., Alison, R. E. & Gospodarowicz, M. K. (1988) Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139: 1220–1224.
Lampe, H., Horwich, A., Norman, A., Nicholls, J. & Dearnaley, D. P. (1997) Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15: 239–245.
Lange, P. H., Narayan, P. & Fraley, E. E. (1984) Fertility issues following therapy for testicular cancer. Sem in Urol 2: 264–274.
Lange, P. H., Chang, W. Y. & Fraley, E. E. (1987) Fertility issues in the therapy of non-seminomatous testicular tumors. Urol Clin North Am 14: 731–747.
Loehrer, PJ Sr (1990) Ifosfamide in testicular cancer. Semin Oncol 17: 2–5.
Moynihan, C. (1987) Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surveys 6: 477–510.
Narayan, P., Lange, P. H. & Fraley, E. E. (1982) Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol 127: 685–688.
Pizzocaro, G., Salvioni, R. & Zanoni, F. (1985) Unilateral lymphadenectomy in intraoperative stage I non-seminomatous germinal testis cancer. J Urol 134: 485–489.
Roth, B. J., Greist, A., Kubilis, P. S., Williams, S. D. & Einhorn, L. H. (1988) Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol 6: 1239–1247.
Weissbach, L., Boedefeld, E. A. & Oberdörster, W. (1985). Modified RLND as a means to preserve ejaculation. In: Testicular Cancer, Khoury S, Kuss R, Murphy GP, et al (eds), pp. 323–334. Alan R. Liss: New York
Whitmore, W. F. Jr (1979) Surgical treatment of adult germinal testis tumors. Semin Oncol 6: 55–68.
Whitmore, W. F. Jr (1982) Surgical treatment of clinical stage I nonseminomatous germ cell tumors of the testis. Cancer Treat Rep 66: 5–10.
Wood, D. P., Herr, H. W., Heller, G., Vlamis, V., Sogani, P. C., Motzer, R. J., Fair, W. R. & Bosl, G. J. (1982) Distribution of retroperitoneal metastases after chemotherapy in patients with non-seminomatous germ cell tumors. J Urol 148: 1812–1816.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Jacobsen, K., Ous, S., Wæhre, H. et al. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 80, 249–255 (1999). https://doi.org/10.1038/sj.bjc.6690347
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690347
